HIV-1 envelope stabilizing mutations

    公开(公告)号:US12138304B2

    公开(公告)日:2024-11-12

    申请号:US17281918

    申请日:2019-09-05

    Abstract: The technology is directed to HIV envelopes which comprise sequence modifications wherein these modifications prevent CD4-induced transitions of the HIV envelope. Specifically, the disclosure provides recombinant HIV-1 Env proteins comprising mutations, wherein the envelope is a protomer, and wherein three protomers form a trimer stabilized by the presence of the mutations. Provided also are compositions comprising envelopes of the technology, and methods of use.

Patent Agency Ranking